- Home /
- Live Rates /
- IONS

IONS
Last Updated: Jun 17, 2026 03:17:51 PM (GMT)
IONS: The current live price is 74.23, reflecting a percentage change of +1.56% from the previous price.
Support and Resistance Levels The pivot point is 73.09, with support levels at 73.09, 73.09, 73.09 and resistance levels also at 73.09, 73.09, 73.09.
Indicators The RSI is at 41.3, indicating a neutral trend. The ATR is at 0.11791, suggesting low volatility. The ADX is at 34.37, confirming a strong trend. The current values for moving averages are: SMA-5 at 73.09, 10 at 73.09, 20 at 73.122, 50 at 73.5661, and 100 at 73.4209. The Parabolic SAR is at 74.20401, indicating a potential continuation of the rally.
Market Sentiment The price is above the pivot point of 73.09, suggesting bullish momentum, supported by the current strong ADX and upward trends in moving averages.
IONS Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (IONS) Ionis Pharmaceuticals Inc.
Company Background
Ionis Pharmaceuticals Inc. (Ticker: IONS) is a pioneering biopharmaceutical company based in the United States, specialized in the discovery and development of RNA-targeted therapeutics. Established in 1989, Ionis has dedicated over three decades to advancing innovative treatments for a variety of diseases, including neurological disorders, cardiovascular diseases, and rare genetic conditions. The company employs its proprietary Ionis technology platform, which enables the creation of drugs that can precisely target and modulate RNA, offering a transformative approach to medicine.
Market Position
Ionis Pharmaceuticals holds a competitive edge in the biopharmaceutical industry, recognized for its scientific expertise and robust pipeline of drug candidates. The company strategically partners with major pharmaceutical firms, enhancing its reach and capacity to bring novel therapies to market. With an extensive portfolio of 48 drugs across various stages of development, including those targeting debilitating conditions like amyloidosis and Huntington's disease, Ionis is positioned as a leader in RNA-targeted therapies. Its focus on unmet medical needs underscores its commitment to improving patient outcomes globally.
Key Financial Highlights
Ionis Pharmaceuticals has demonstrated solid financial performance, bolstered by strategic collaborations and a diverse pipeline. As of the latest fiscal reports, the company has recorded significant revenue growth driven by its partnered programs and royalties from approved drugs like Spinraza, which have contributed to its financial stability. With a strong balance sheet and effective cost management, Ionis is well-equipped to invest in research and development, ensuring continued innovation. The company is also committed to delivering shareholder value through strategic initiatives and raising its market presence internationally.
Industry Highlights
The biopharmaceutical sector is experiencing rapid growth, propelled by advancements in personalized medicine and RNA therapeutics. Ionis Pharmaceuticals capitalizes on emerging trends, positioning itself to leverage new opportunities in the evolving healthcare landscape. As global demand for innovative treatments rises, Ionis is on the forefront, committed to transforming the future of medicine through cutting-edge technology and pioneering research.
How to Buy or Trade Ionis Pharmaceuticals Inc. Stock (IONS) with AvaTrade
Trading or investing in Ionis Pharmaceuticals Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol IONS, which represents Ionis Pharmaceuticals Inc.. Before placing a trade, review the live Ionis Pharmaceuticals Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Ionis Pharmaceuticals Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Ionis Pharmaceuticals Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
<% signal.analyst %>
